RE: Therapeutics17 Mar 2021 20:26
And on it continues....
Speculation, guesswork, worry, frustration.
As I said in my last post, a while ago, before being rudely told to do one.
This is what happens when the CEO provides absolutely no updates. I’m not talking about RNS, I mean just the odd tweet, video, update about current position of trial delivery.
This will immediately set people’s mind at rest, yes that’s us, the investors in the company.
Poor PR and disappointing.
I’m sure news, whether good or bad, will come at some point.
But that is the same for any company.
Point made.
Good luck to everyone, as many are invested heavily, me included. Fortunately, with a low average! Some unfortunately aren’t.